RNA Targeting Small Molecule Drug Discovery Market to Grow with a CAGR of 21.93% through 2030
The increasing prevalence of
RNA-related diseases is expected to drive the growth of Global RNA Targeting
Small Molecule Drug Discovery Market during the forecast period, 2026-2030.
According to TechSci Research
report, “RNA Targeting Small Molecule Drug Discovery Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2030” the
Global RNA Targeting Small Molecule Drug Discovery market stood at USD 1.68 billion in 2024 and is anticipated to growth with a CAGR of 21.93% in the forecast period trough 2030. This
can be ascribed to the growing demand for new drugs owing to the high burden of
chronic and infectious diseases and the increased research and development
costs. Additionally, the growing demand for generics and biosimilars are the
major factors driving the growth of the market during the forecast period.
Also, the growing demand for innovative and effective medicine will further
boost the growth of the global RNA Targeting Small Molecule Drug Discovery
market in the forecast period. Besides, governments around the world are
providing support for the development of the healthcare industry, including
funding for research and development, which is driving the demand for the
Global RNA Targeting Small Molecule Drug Discovery Market during the forecast
period. Similarly, growing research centers and biopharmaceuticals sectors are
the major factors driving the growth of the market over the years.
However, small molecules can
bind to multiple targets, including unintended targets, which can lead to
unwanted side effects which can slow down the growth of the global RNA
Targeting Small Molecule Drug Discovery market in the forecast period. Also,
RNA-targeted small molecule drugs need to be delivered to the target cells and
tissues to exert their therapeutic effects. Delivering small molecules to
specific cells or tissues can be challenging, which may hamper the growth of
the market during the forecast period. Similarly, RNA-targeted small molecule
drugs face competition from other therapeutic modalities, including monoclonal
antibodies, gene therapy, and RNA-based therapeutics which may restrict the
growth of the market.
Browse over XX market data
Figures spread through XX Pages and an
in-depth TOC on "Global RNA Targeting Small Molecule Drug Discovery Market.”
Global RNA Targeting Small
Molecule Drug Discovery market can be segmented by Indication, End User, Region
and Competitive Landscape.
Based on the Indication, Cancer category shows the fastest growth during the forecast period. This can be ascribed
to the growing prevalence of cancer diseases due to consuming alcohol and
smoking along with growing research and development for developing new drugs.
Also, the high prevalence of chronic diseases such as diabetes, HIV, and other
diseases is further contributing to the demand for developing innovative
therapies which will further drive the growth of the market during the forecast
period.
Based on Region, The Asia Pacific region is emerging as a rapidly growing hub for RNA-targeting small molecule drug discovery. This growth is driven by several factors, including increasing investments in biotechnology, supportive government initiatives, and a rising prevalence of chronic diseases. Countries like China, India, and Japan are at the forefront, with expanding pharmaceutical industries and a growing focus on innovative therapeutic approaches. The region's large patient population and unmet medical needs further contribute to the demand for advanced RNA-targeted therapies. Collaborations between local and international biotech firms are also fostering innovation and accelerating the development of new treatments. As a result, Asia Pacific is becoming a significant player in the global RNA-targeting small molecule drug discovery landscape, offering promising opportunities for research and development.
Major companies operating in the
Global RNA Targeting Small Molecule Drug Discovery Market are:
- Accent Therapeutics, Inc.
- Anima Biotech Inc.
- Arrakis Therapeutics, Inc.
- AstraZeneca Plc
- Epics Therapeutics, Inc.
- Expansion Therapeutics, Inc.
- F. Hoffmann-La Roche AG
- H3 Biomedicine Inc.
- PTC Therapeutics, Inc.
- Ribometrix, Inc.
Download Free Sample Report
Customers can also request for
10% free customization on this report.
“North America was expected to
dominate in the Global RNA Targeting Small Molecule Drug Discovery market due
to the presence of many pharmaceutical and biotechnology companies in the
region, as well as significant government funding for research and development
in the life sciences. Similarly, the growing demand for RNA Targeting Small
Molecule Drug Discovery , as these technologies are critical for developing new
treatments and therapies along with the growing prevalence of chronic diseases
such as cancer is expected to create lucrative growth in the market during the
forecast period. Also, growing government funding for healthcare infrastructure
and a large and rapidly expanding population is expected to drive the growth of
the market during the forecast period. Furthermore, increased R&D spending
in RNA molecule research and increased market demand for high-quality
analytical equipment for RNA analysis will further create lucrative
opportunities for market growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.
“RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others), By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others), By Region and Competition, 2020-2030F”, has
evaluated the future growth potential of global RNA Targeting Small Molecule
Drug Discovery market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision-makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the Global RNA Targeting
Small Molecule Drug Discovery market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com